Repertoire Genesis, Inc. has raised 500 million yen in series B funding round through stock allocations to the University of Tokyo Edge Capital Co., Ltd. (UTEC, CEO: Tomotaka Goji) and Beyond Next Ventures Inc. (CEO: Tsuyoshi Ito).

This funding will accelerate the company's contribution to the optimal medical care to each individual patient by committing to research development and business expansion in the development of new diagnostics and therapeutics.